Growing surgical procedures are expected to drive market expansion in the near future at a CAGR of 7.00% during the forecast period from 2024 to 2032

Market Research Future (MRFR) has published on the “Global Antimicrobial Wound Gel Market”. The Market is estimated to register a CAGR of 7.00% during the forecast period of 2024 to 2032.

Market Highlights

The global Antimicrobial Wound Gel Market is accounted to register a CAGR of 7.00% during the forecast period and is estimated to reach USD 2.4 billion by 2032.

Wound treatment is critical for preventing infections and improving patient health. It is one of the most serious safety problems for healthcare workers around the world. The growing prevalence of disorders such as venous stasis ulcers, diabetic ulcers, and pressure ulcers is expected to drive the antimicrobial dressings market in the next years. The World Health Organization reports that burns cause over 1,80,000 fatalities each year. Rising incidences of these injuries will drive market growth in the coming years. In addition, the increasing geriatric population, who are more susceptible to wounds and injuries as their skin gets damaged easily due to the lack of cell multiplication quickly, technological advancements in wound dressing applications, and rising per capita healthcare expenditure are expected to fuel the market.

Key Players

MRFR recognizes the following companies as the key players in the global Antimicrobial Wound Gel Market— 3M, Smith & Nephew, Cardinal Health, Convatec, Inc., B. Braun SE, Coloplast Corp., McKesson Corporation, Mölnlycke Health Care AB, Paul Hartmann AG, Medline Industries.

Segmental Analysis

The global Antimicrobial Wound Gel Market has been segmented based on Product, Application, and End-use.

The market is segmented by product into Silver Dressings, Povidone-iodine Dressings, PHMB Dressings, And Others. Silver wound dressing accounts for the largest market segment. Silver wound dressings are antibacterial dressings that contain silver as an active ingredient.

Application has divided the worldwide Antimicrobial Wound Gel Market into Antimicrobial Wound Dressings for Chronic Wounds And Antimicrobial Wound Dressings for Acute Wounds. The Antimicrobial Wound Dressings for Chronic Wounds segment is expected to lead the market in 2023. The dominance can be linked to an increase in the number of persons suffering from chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other types.

Based on End-use, the global Antimicrobial Wound Gel Market is divided into two segments: Antimicrobial Dressings for Hospitals, Antimicrobial Dressings for Outpatient Facilities, Antimicrobial Dressings for Home Care And Antimicrobial Dressings for Research & Manufacturing. Antimicrobial Dressings for Hospitals dominated the market in 2023. This can be attributed to a rising hospital sector, higher surgery rates, and a growing patient population across all age groups.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Antimicrobial Wound Gel Market Research Report

Regional Analysis

The global Antimicrobial Wound Gel Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Antimicrobial Wound Gel Market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Antimicrobial Wound Gel Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Antimicrobial Wound Gel Market comprises of the Middle East, Africa, and Latin America.

In 2023, North America had the greatest market share for antimicrobial wound care dressings due to its well-developed healthcare infrastructure and widespread access to medical facilities such as hospitals and outpatient care centers. This innovative healthcare system meets the requirement for specialized wound care products, such as antimicrobial dressings. The region has a high frequency of chronic disorders, including diabetes and obesity, which can result in chronic wounds. As the prevalence of these disorders grows, so does the demand for wound care treatments, such as antimicrobial dressings. North America's population is rapidly aging, with a high proportion of people aged 65 and up. Older people are more vulnerable to persistent wounds, surgical operations, and other medical disorders requiring wound care.

Moreover, Europe is expected to have a CAGR of 5.3% during the predicted period. Germany has around 900,000 people with chronic wounds. Hard-to-heal wounds are associated with high treatment costs and are typically treated in outpatient care settings. Wound dressings are the main cost drivers in venous leg ulcer (VLU) therapy. In 2018, approximately 1% of the German population was diagnosed with a VLU, with a higher frequency among those over the age of 60 (3.9%). Antibacterial wound dressings (e.g., silver) are routinely used to treat chronic ulcers with high bacterial contamination.

Additionally, Asia-Pacific is likely to expand at the fastest CAGR throughout the forecast period. This is due to an increasing senior population, traffic accidents, and incidences of diabetes and burns. India is anticipated to be the world's future diabetic capital. Burning incidents are on the rise in nations such as India due to a lack of safety measures. According to the World Health Organisation (WHO), about one million persons in India suffer from moderate to severe burns each year. Road accidents can result in severe wounds that require specialized wound care solutions to heal. These factors are driving expansion in the advanced wound care market, which includes antimicrobial wound dressing in this region.

The rest of the world's Antimicrobial Wound Gel Market is segmented into three regions: the Middle East, Africa, and Latin America. This is attributable to causes such as the increasing prevalence of chronic wounds such as pressure ulcers, diabetic foot ulcers, etc., and a huge geriatric population base.

Key Findings of the Study

• The global Antimicrobial Wound Gel Market is expected to reach USD 2.4 billion by 2032, at a CAGR of 7.00% during the forecast period.


• Asia-Pacific is likely to expand at the fastest CAGR throughout the forecast period. This is due to an increasing senior population, traffic accidents, and incidences of diabetes and burns.


• Based on application, the Antimicrobial Wound Dressings for Chronic Wounds segment is expected to lead the market in 2023.


• 3M, Smith & Nephew, Cardinal Health, Convatec, Inc., B. Braun SE, Coloplast Corp., McKesson Corporation, Mölnlycke Health Care AB, Paul Hartmann AG, and Medline Industries are the key market players.